JD Supra

IPR or EPR? Five Scenarios and a Decision Tree for Post-Grant Patent Challengers in the Life Sciences

The total number of petitions for inter partes review (IPR) at the Patent Trial and Appeal Board (PTAB) has plummeted over ...